每年研究計畫
個人檔案
學歷
- 1983 國立台灣大學醫學系醫學博士
研究專長
- 細胞訊息傳遞
- 奈米醫學
- 腫瘤學
- 臨床人體試驗
經歷
- 2019年2月～ 迄今 腫瘤醫學部主任
- 2018年1月～迄今 奈米醫學研究中心主任
- 2017年08月~迄今 國立成功大學醫學院附設醫院內科主任
- 2011年10月~2017年07月 國立成功大學醫學院附設醫院癌症中心主任
- 2006年01月~2011年09月 國立成功大學醫學院附設醫院臨床試驗中心主任
- 2004年08月~迄今 國立成功大學醫學系內科學科教授
- 2004年07月~迄今 國立成功大學醫學院附設醫院血液腫瘤科主任
- 1990年08月~迄今 國立成功大學醫學院附設醫院主治醫師
指紋 查看啟用 Wu-Chou Su 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 27 類似的檔案
Lung Neoplasms
Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Smoking
Medicine & Life Sciences
網絡
國家層面的近期外部合作。點選圓點深入探索詳細資料。
研究計畫 1997 2020
研究成果 1987 2020
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
Nishio, M., Felip, E., Orlov, S., Park, K., Yu, C. J., Tsai, C. M., Cobo, M., McKeage, M., Su, W. C., Mok, T., Scagliotti, G. V., Spigel, D. R., Viraswami-Appanna, K., Chen, Z., Passos, V. Q. & Shaw, A. T., 2020 一月 1, (Accepted/In press) 於 : Journal of Thoracic Oncology.研究成果: Article
開啟存取
Safety
Survival
Disease-Free Survival
Research Personnel
Confidence Intervals
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas
Lin, C. C., Arkenau, H. T., Lu, S., Sachdev, J., de Castro Carpeño, J., Mita, M., Dziadziuszko, R., Su, W. C., Bobilev, D., Hughes, L., Chan, J., Zhang, Z. Y. & Weiss, G. J., 2019 七月 16, 於 : British Journal of Cancer. 121, 2, p. 131-138 8 p.研究成果: Article
開啟存取
Lymphoma
Neoplasms
Safety
Non-Small Cell Lung Carcinoma
Maximum Tolerated Dose
Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC
Lin, C. Y., Chang, C. C., Su, P. L., Lin, C. C., Tseng, Y. L., Su, W. C., Yen, Y. T. & Patel, G., 2019 八月 1, 於 : Medicine (United States). 98, 33, e16766.研究成果: Article
開啟存取
Neuroimaging
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Disease-Free Survival
Epidermal Growth Factor Receptor
1
引文
(Scopus)
Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up
Yang, S. C., Kuo, C. W., Lai, W. W., Lin, C. C., Su, W. C., Chang, S. M. & Wang, J. D., 2019 十一月, 於 : Journal of Thoracic Oncology. 14, 11, p. 1892-1900 9 p.研究成果: Article
開啟存取
Lung Neoplasms
Health
Quality of Life
Drug Therapy
Therapeutics
Erratum: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy (Oncotarget (2015) 6 (13671–13687) DOI: 10.18632/oncotarget.3701)
Hsu, T. I., Chen, Y. J., Hung, C. Y., Wang, Y. C., Lin, S. J., Su, W. C., Lai, M. D., Kim, S. Y., Wang, Q., Qian, K., Goto, M., Zhao, Y., Kashiwada, Y., Lee, K. H., Chang, W. C. & Hung, J. J., 2019 一月 1, 於 : Oncotarget. 10, 60, p. 6536-6537 2 p.研究成果: Comment/debate
Lung Neoplasms
Growth
Neoplasms
betulinic acid
論文
Characterization of glycosylation patterns of interleukin-6 between non-small lung cancer cell lines and macrophage
作者: 婷卉, 黃., 2016 二月 2監督員: Su, W. (Supervisor)
學生論文: Master's Thesis
Development of multifunctional FePt nanoparticle for targeted imaging agent and as a novel sensitizer for radiotherapy
作者: 婉莉, 施., 2016 八月 30監督員: Su, W. (Supervisor)
學生論文: Master's Thesis
Interaction of thrombomodulin and plasminogen activating system in lung cancer cell invasiveness and its clinical outcome correlation
作者: 瑞鴻, 蔡., 2017 九月 1監督員: Su, W. (Supervisor)
學生論文: Master's Thesis
Studying mechanisms underlying ER-stress induction by LY294002@PLGA nanodrug
作者: 宜珊, 李., 2015 二月 9監督員: Su, W. (Supervisor)
學生論文: Master's Thesis
The mechanism of vinorelbine-induced apoptosis and radiosensitization in lung cancer cells
作者: 威鑫, 邱., 2014 八月 22監督員: Su, W. (Supervisor)
學生論文: Doctoral Thesis